GlaxoSmithKline

Business Stephanie Simon

Google spinoff teams with pharma giant to treat disease by zapping nerves

Pharmalot Ed Silverman

STAT Plus: Pharmalot, Pharmalittle: Brexit, schmexit. Glaxo invests $360 million in the UK

Pharmalot Ed Silverman

STAT Plus: FDA sends stern warning to Glaxo over contamination at a penicillin plant

Pharmalot Ed Silverman

STAT Plus: Former Glaxo scientists and the feds fight over reviewing allegedly stolen documents

Pharmalot Ed Silverman

STAT Plus: Most scientists believe there is a ‘crisis’ reproducing experiments

Pharmalot Ed Silverman

STAT Plus: Pharmalot, Pharmalittle: Feds probe Sun Pharma over generic pricing

Pharmalot Ed Silverman

STAT Plus: Pharmalot, Pharmalittle: Pfizer syphilis treatment in short supply

Pharmalot Ed Silverman

STAT Plus: Up and down the ladder: The latest comings and goings

Pharmalot Ed Silverman

Glaxo, other drug makers appeal UK fines for pay-to-delay deals

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Glaxo may have to boost pay for its next CEO

Exclusive Ed Silverman

Glaxo probing bribery accusations in Yemen

Pharmalot Ed Silverman

Glaxo widening access to its medicines in poor countries

Pharmalot Ed Silverman

Novartis is accused of paying bribes in Turkey to boost prescriptions

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Johnson & Johnson to pay $498M over hip implant injuries

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Senate committee holds hearing on drug prices

Pharmalot Ed Silverman

Why, in the age of Martin Shkreli, patients are still happy with pharma companies

Pharmalot Ed Silverman

STAT Plus: Pharmalot, Pharmalittle: Indian drug makers pursuing acquisitions, Mass. AG looking into Gilead